摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

LY-2090314 ethanol solvate | 1097945-23-7

中文名称
——
中文别名
——
英文名称
LY-2090314 ethanol solvate
英文别名
ethanol;3-[6-fluoro-10-(piperidine-1-carbonyl)-1,10-diazatricyclo[6.4.1.04,13]trideca-2,4,6,8(13)-tetraen-3-yl]-4-imidazo[1,2-a]pyridin-3-ylpyrrole-2,5-dione
LY-2090314 ethanol solvate化学式
CAS
1097945-23-7
化学式
C30H31FN6O4
mdl
——
分子量
558.6
InChiKey
PQDRKXRENQDFMP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.42
  • 重原子数:
    41
  • 可旋转键数:
    2
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    112
  • 氢给体数:
    2
  • 氢受体数:
    6

文献信息

  • HEMATOPOIETIC NEOPLASM CHEMOTHERAPY
    申请人:Chedid Marcio
    公开号:US20100261712A1
    公开(公告)日:2010-10-14
    A method and medicament for treating mixed lineage leukemia; translocated mixed lineage leukemia; translocated mixed lineage leukemia based acute myelogenous leukemia; translocated mixed lineage leukemia based acute lymphoid leukemia; a non-MLL based chronic myeloproliferative disorder, or non-MLL based acute lymphoid leukemia is provided.
    本发明提供了一种治疗混合谱系白血病的方法和药物;移位混合谱系白血病;基于移位混合谱系白血病的急性髓系白血病;基于移位混合谱系白血病的急性淋巴细胞白血病;非MLL基础的慢性增生性骨髓疾病或非MLL基础的急性淋巴细胞白血病的药物。
  • POTENTIATION OF CANCER CHEMOTHERAPY BY 7-(2, 5- DIHYDRO- 4-IMIDAZO [1, 2-A] PYRIDINE-3-YL-2,5-DIOXO-IH-PYRROL-3-YL)-9-FLUORO-1,2,3,4 TETRAHYDRO -2-(1-PIPERIDINYL-CARBONYL)-PYRROLO [3,2,1-JK] [1,4] BENZODIAZEPINE
    申请人:Aburub Aktham
    公开号:US20100166884A1
    公开(公告)日:2010-07-01
    A method for treating gastric cancer, ovarian cancer, non-small cell lung cancer, or colorectal cancer in a patient is described, as well as pharmaceutical compositions comprising 7-(2,5-dihydro-4-imidazo[1,2-a]pyridine-3-yl-2,5-dioxo-IH-pyrrol-3-yl)-9-fluoro-1,2,3,4-tetrahydro-2-(1-piperidinyl-carbonyl)-pyrrolo[3,2,1-jk][1,4]benzodiazepine, useful for the method and a process for preparing said compositions.
    本发明涉及一种治疗患有胃癌、卵巢癌、非小细胞肺癌或结直肠癌的患者的方法,以及包含7-(2,5-二氢咪唑[1,2-a]吡啶-3-基)-2,5-二氧代-IH-吡咯-3-基)-9-氟-1,2,3,4-四氢-2-(1-哌啶基-羰基)-吡咯[3,2,1-jk][1,4]苯二氮平的制药组合物,用于该方法和制备该组合物的过程。
  • POTENTIATION OF CANCER CHEMOTHERAPY BY 7-(2, 5- DIHYDRO- 4-IMIDAZO [1, 2-A] PYRIDINE-3-YL-2,5-DIOXO-IH-PYRROL-3-YL)-9-FLUORO-1,2,3,4 TETRAHYDRO -2-(1-PIPERIDINYL-CARBONYL)-PYRROLO [3,2,1-JK] [1,4] BENZODIAZEPINE
    申请人:ELI LILLY AND COMPANY
    公开号:US20130039996A1
    公开(公告)日:2013-02-14
    An improved method for treating gastric cancer, ovarian cancer, non-small cell lung cancer, or colorectal cancer in a patient is described, as well as pharmaceutical compositions useful for the method and a process for preparing said compositions.
    本发明描述了一种改进的方法,用于治疗患有胃癌、卵巢癌、非小细胞肺癌或结直肠癌的患者,以及用于该方法的制药组合物和制备该组合物的过程。
  • POTENTIATION OF CANCER CHEMOTHERAPY
    申请人:Eli Lilly & Company
    公开号:EP2173348B1
    公开(公告)日:2015-12-09
  • BENZODIAZEPINE DERIVATIVE FOR THE TREATMENT OF HEMATOPOIETIC NEOPLASM AND LEUKEMIA
    申请人:Eli Lilly and Company
    公开号:EP2419106A1
    公开(公告)日:2012-02-22
查看更多